195,954 Shares of Arteris, Inc. $AIP Acquired by CenterBook Partners LP

CenterBook Partners LP bought a new stake in shares of Arteris, Inc. (NASDAQ:AIP) in the third quarter, Holdings Channel reports. The fund bought 195,954 shares of the company’s stock, valued at approximately $4,632,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of AIP. Versant Capital Management Inc lifted its holdings in shares of Arteris by 33.7% in the second quarter. Versant Capital Management Inc now owns 1,150 shares of the company’s stock worth $56,000 after buying an additional 290 shares in the last quarter. Farther Finance Advisors LLC boosted its position in shares of Arteris by 106.0% in the third quarter. Farther Finance Advisors LLC now owns 1,730 shares of the company’s stock valued at $41,000 after acquiring an additional 890 shares during the period. Sterling Capital Management LLC boosted its position in shares of Arteris by 612.5% in the third quarter. Sterling Capital Management LLC now owns 1,197 shares of the company’s stock valued at $28,000 after acquiring an additional 1,029 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in Arteris during the second quarter valued at approximately $53,000. Finally, Nisa Investment Advisors LLC grew its stake in Arteris by 55.9% during the third quarter. Nisa Investment Advisors LLC now owns 4,714 shares of the company’s stock valued at $111,000 after acquiring an additional 1,690 shares in the last quarter. 64.36% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In related news, CEO K Janac sold 100,000 shares of the firm’s stock in a transaction that occurred on Thursday, October 1st. The shares were sold at an average price of $23.82, for a total value of $2,382,000.00. Following the sale, the chief executive officer directly owned 8,129,071 shares of the company’s stock, valued at $193,634,471.22. This trade represents a 1.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, COO Laurent Moll sold 12,219 shares of Arteris stock in a transaction that occurred on Monday, October 5th. The shares were sold at an average price of $24.29, for a total transaction of $296,799.51. Following the sale, the chief operating officer owned 194,659 shares of the company’s stock, valued at approximately $4,728,267.11. The trade was a 5.91% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 478,631 shares of company stock valued at $10,823,565 in the last 90 days. 23.30% of the stock is owned by company insiders.

Arteris Price Performance

Shares of NASDAQ AIP opened at $17.80 on Friday. The stock’s 50-day simple moving average is $21.39 and its two-hundred day simple moving average is $24.94. Arteris, Inc. has a twelve month low of $12.06 and a twelve month high of $50.26. The firm has a market capitalization of $874.87 million, a P/E ratio of -20.00 and a beta of 1.93. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 0.03.

Arteris (NASDAQ:AIP) last issued its quarterly earnings results on Thursday, November 5th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.04) by $0.02. Arteris had a negative return on equity of 184.29% and a negative net margin of 44.83%. The firm had revenue of $25.77 million during the quarter, compared to the consensus estimate of $24.57 million. As a group, equities analysts anticipate that Arteris, Inc. will post -0.68 EPS for the current fiscal year.

Analysts Set New Price Targets

AIP has been the topic of a number of analyst reports. Rosenblatt Securities reaffirmed a “buy” rating and set a $38.00 target price on shares of Arteris in a report on Friday, August 7th. Oppenheimer began coverage on shares of Arteris in a report on Thursday, July 16th. They issued an “outperform” rating and a $40.00 price target for the company. Weiss Ratings upgraded shares of Arteris from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 21st. Roth Capital began coverage on shares of Arteris in a research report on Tuesday, August 4th. They set a “buy” rating and a $40.00 price target for the company. Finally, Jefferies Financial Group decreased their price target on shares of Arteris from $50.00 to $40.00 and set a “buy” rating on the stock in a report on Friday. Six equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $35.86.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

• Positive Sentiment: Arteris reported Q3 revenue of $25.8 million, above the roughly $24.6 million consensus estimate. Its loss of $0.02 per share was narrower than analysts expected and improved from a $0.09 loss a year earlier. Arteris Q3 results and guidance
• Positive Sentiment: The company forecast Q4 revenue of $25.7 million to $26.7 million and FY2026 revenue of $98.5 million to $99.5 million. It also set a $103 million to $107 million target for annual contract value plus royalties, offering investors visibility into expected business activity. Arteris FY2026 forecast
• Positive Sentiment: Arteris surpassed 1,000 customer chip-design starts. The company says AI accounted for about half of its recent projects, pointing to potential demand from a fast-growing market. Arteris surpasses 1,000 customer design starts
• Negative Sentiment: Despite the improvement and estimate beat, Arteris remains loss-making, so investors may continue to watch its path toward profitability. Arteris Q3 loss and revenue results

Arteris Profile

Arteris, Inc is a semiconductor intellectual property (IP) company that provides technology used to design and integrate complex systems-on-chip (SoCs). Its products help semiconductor and system developers connect, manage and verify the various processing, memory and specialized functional components incorporated into modern chips.

The company’s portfolio includes network-on-chip (NoC) interconnect and semiconductor IP solutions, including its FlexNoC interconnect technology, Ncore cache-coherent interconnect IP and CodaCache products.